Physician profile
Scott Patrick Grogan
NPI 1588706568
$5,885.08
in general payments reported to CMS, 2019-2025
7 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $125 · 2024: $4,420 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,500 · Consulting Fee: $2,050 · Food and Beverage: $285 · Gift: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,500.00 |
| Consulting Fee | $2,050.00 |
| Food and Beverage | $285.08 |
| Gift | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exo Imaging, INC. | $3,550.00 | 2024 | Exo Iris |
| Vave Health, INC. | $1,200.00 | 2025 | Vave Wireless Ultrasound System |
| Fujifilm Sonosite, INC. | $995.00 | 2023-2024 | |
| Corcept Therapeutics | $47.68 | 2025 | Korlym |
| Exact Sciences Corporation | $41.73 | 2025 | Cologuard Collection Kit |
| Abbott Laboratories | $32.05 | 2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $18.62 | 2025 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Grogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.